An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1

NCT01571206 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
174
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celltrion